New Delhi, July 9 -- Contract research, development and manufacturing organization (CRDMO) Anthem Biosciences, which will launch its Rs.3,395 crore initial public offering (IPO) next week, is banking ... Read More
New Delhi, July 4 -- Aster DM Healthcare's merger with Blackstone-backed Quality Care India Ltd (QCIL) was an inflection point for the hospital chain as it embarks on an ambitious expansion plan, depu... Read More
New Delhi, July 3 -- Mumbai-headquartered drugmaker Cipla Ltd is bolstering its focus on a pipeline of drugs to fight infections caused by bacterial antimicrobial resistance in India, a growing health... Read More
New Delhi, July 1 -- Apollo Hospitals Enterprise Limited (AHEL) late on Monday announced plans to list its omnichannel pharmacy and digital health business in the next 18-21 months as part of a strate... Read More
New Delhi, June 30 -- Ahmedabad-based drugmaker Torrent Pharmaceuticals will not to make leadership changes at JB Chemicals and Pharmaceuticals, its management told investors in a call on Monday, a da... Read More
Mumbai, June 30 -- Ahmedabad-based drugmaker Torrent Pharmaceuticals is set to acquire a controlling stake in JB Chemicals and Pharmaceuticals (JB Pharma) from global investment firm KKR, at an equity... Read More
Mumbai, June 30 -- Ahmedabad-based drugmaker Torrent Pharmaceuticals is set to acquire a controlling stake in JB Chemicals and Pharmaceuticals (JB Pharma) from global investment firm KKR, at an equity... Read More
New Delhi, June 29 -- Ahmedabad-based drugmaker Torrent Pharmaceuticals is set to acquire a controlling stake in JB Chemicals and Pharmaceuticals (JB Pharma) from global investment firm KKR, at an equ... Read More
New Delhi, June 26 -- Just months after introducing its weight-loss drug Mounjaro in India, US-based Eli Lilly is set to roll out a more convenient, pen-filled version-escalating its rivalry with Novo... Read More
New Delhi, June 24 -- Novo Nordisk launched its blockbuster weight loss drug Wegovy (Semaglutide) in India on Tuesday, ahead of a patent expiry next year, which will see generic versions flooding the ... Read More